Cambridge Cognition (LON:COG) Stock Price Up 16.9%

Cambridge Cognition Holdings Plc (LON:COGGet Free Report)’s stock price was up 16.9% during mid-day trading on Friday . The stock traded as high as GBX 45 ($0.59) and last traded at GBX 45 ($0.59). Approximately 433,073 shares changed hands during trading, an increase of 624% from the average daily volume of 59,778 shares. The stock had previously closed at GBX 38.50 ($0.50).

Cambridge Cognition Stock Up 1.3 %

The firm has a market cap of £16.36 million, a P/E ratio of -975.00 and a beta of 0.72. The company has a quick ratio of 0.96, a current ratio of 0.65 and a debt-to-equity ratio of 92.53. The company has a fifty day simple moving average of GBX 43.56 and a 200-day simple moving average of GBX 46.75.

Cambridge Cognition Company Profile

(Get Free Report)

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.

Further Reading

Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.